Agile Therapeutics Inc is categorized under Medical Research in Princeton, NJ and active since 1998.
Agile Therapeutics Inc was established in 1998, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact AL Altomari, Chief Executive Officer at the company’s single location by writing to 101 Poor Farm Road # 3, Princeton, New Jersey NJ 08540 or by phoning (609) 683-1880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Agile Therapeutics Inc |
Contact Person: | AL Altomari, Chief Executive Officer |
Address: | 101 Poor Farm Road # 3, Princeton, New Jersey 08540 |
Phone Number: | (609) 683-1880 |
Website Address: | agiletherapeutics.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 6214930 |
Share This Business: |
Agile Therapeutics Inc was started in 1998 to provide professional Medical Research under the SIC code 8733 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact AL Altomari, Chief Executive Officer for inquiries that concern Agile Therapeutics Inc by calling the company number (609) 683-1880, as your correspondence is most welcome. Additionally, the physical location of the single location of Agile Therapeutics Inc can be found at the coordinates 40.382692,-74.651762 as well as the street address 101 Poor Farm Road # 3 in Princeton, New Jersey 08540.
For its online presence, you may visit Agile Therapeutics Inc’s website at agiletherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.